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Abstract
‘Medical Tourism’ – the phenomenon of people travelling abroad to access medical treatment - has received increasing
attention in academic and popular media. This paper reports findings from a study examining effect of inbound and
outbound medical tourism on the UK NHS, by estimating volume of medical tourism and associated costs and benefits. A
mixed methods study it includes analysis of the UK International Passenger Survey (IPS); interviews with 77 returning UK
medical tourists, 63 policymakers, NHS managers and medical tourism industry actors policymakers, and a review of
published literature. These informed costing of three types of treatments for which patients commonly travel abroad:
fertility treatment, cosmetic and bariatric surgery. Costing of inbound tourism relied on data obtained through 28 Freedom-
of-Information requests to NHS Foundation Trusts. Findings demonstrate that contrary to some popular media reports, far
from being a net importer of patients, the UK is now a clear net exporter of medical travellers. In 2010, an estimated 63,000
UK residents travelled for treatment, while around 52,000 patients sought treatment in the UK. Inbound medical tourists
treated as private patients within NHS facilities may be especially profitable when compared to UK private patients, yielding
close to a quarter of revenue from only 7% of volume in the data examined. Costs arise where patients travel abroad and
return with complications. Analysis also indicates possible savings especially in future health care and social costs averted.
These are likely to be specific to procedures and conditions treated. UK medical tourism is a growing phenomenon that
presents risks and opportunities to the NHS. To fully understand its implications and guide policy on issues such as NHS
global activities and patient safety will require investment in further research and monitoring. Results point to likely impact
of medical tourism in other universal public health systems.
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Introduction
The phenomenon of people travelling abroad to access medical
treatment – commonly termed ‘Medical Tourism’ – has received
increasing attention in academic and popular media [1]. The
confluence of available and affordable air travel, internet-based
marketing by providers, and an increasing requirement for out-of-
pocket expenditure, even in universal public health care systems
such as the UK NHS, suggests that increasing numbers of patients
may consider travelling for treatment. The PIP scandal highlighted
challenges for UK patients in seeking redress from private
providers, especially where these may be based in other
jurisdictions [2,3].
As the new NHS reforms introduce yet greater market elements,
including the removal of the cap on income from private patients
[4], and the EU Directive on crossborder healthcare is
implemented which codifies rights around patient mobility [5], it
is imperative to consider the challenges and opportunities that
medical tourism – inward and outward – may present to the NHS
[6].
Yet, reliable information on even the basic number, character-
istics, motivations and experiences of such patients is scarce, as
patients arrange and pay for such care privately [7]. Indeed, a
recent review of medical tourism literature [8] found that
academic literature relies heavily on opaque data from private
consultancy firms or unverified media reports [9,10]. In the
absence of even the basic level of information in these areas, it is
understandable that rhetoric has filled the vacuum. In this paper
we present evidence from the largest study yet conducted
concerning medical tourism, undertaken from an NHS perspec-
tive, to provide a firmer footing for debate and discussion by
health professionals, NHS managers and those involved in the
wider policy-making context.
Methods
Authors interviewed 77 UK medical tourists and 63 other UK
stakeholders between March 2011 and August 2012. Interviewees
gave written consent to participate in the study. Interviews were
recorded, transcribed and thematically analysed. The study
received ethical clearance from the National NHS Ethics review
process submitted through the Sheffield Research Ethics Com-
mittee approval (11/H1308/3).
Analysis is three-fold: (i) the volume and characteristics of
outbound and inbound UK medical tourists is based upon the
International Passenger Survey (IPS); (ii) assessment of NHS
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income from foreign patients is based upon freedom-of-informa-
tion requests submitted to 28 NHS Foundation Trust hospitals;
and (iii) evaluation of the challenges encountered, costs incurred
and potential savings for the NHS is based on a review of
published and grey literature and interviews with UK nationals,
NHS managers and policy makers. Each of these is described
below.
Analysis of the International Passenger Survey (IPS)
The IPS, conducted by the UK Office of National Statistics
(ONS), collects information from passengers as they enter or leave
the UK. Passengers are randomly selected as they travel through
passport control and a brief survey is administered. One of the
survey questions asks passengers to define their primary purpose
for travel; ‘medical treatment’ is one of the answers recorded, thus
providing insight into the number of passengers who self-declare
that they are travelling for medical treatment.
The IPS dataset from 2000–2010, from the Office of National
Statistics (ONS), was analysed by two authors independently,
triangulating results. Data from the IPS, interviews, literature and
NHS tariffs were used to calculate cost impacts. Authors used the
different data sources accessed to carefully triangulate and better
understand the reliability of the data from the IPS, which is
reflected on in the discussion.
FOI Requests
Submitted to 28 Foundation Trust hospitals on volume and
income from international private patients. Trusts were purposely
selected to be those most likely to be visited by inbound tourists
i.e., large and well-known Trusts, such as Great Ormond Street
Hospital for Sick Children, many of which are based in London.
Data on foreign patients was analysed to understand the potential
of earnings from foreign patients.
Qualitative Analysis
Authors interviewed 77 UK residents who travelled abroad for
treatment and 63 other UK stakeholders between March 2011
and August 2012. Interviews were recorded, transcribed and
thematically analysed. The study received ethical clearance from
the National NHS Ethics review process.
Results
While the level of inward travel of foreign patients to the UK
(although not necessarily the NHS) has been relatively stable over
the last decade, there has been a substantial increase in the
number of UK residents travelling abroad to access medical
treatment, as indicated in Figure 1.
Destination of UK Outbound Medical Travellers
Figure 2 shows UK residents most commonly travel for medical
treatment to North, West, and Southern Europe with France
being the most visited country over the decade.
Examining this in greater detail (Fig 3) suggests that Central and
Eastern Europe are second most popular, and that Poland and
Hungary are increasingly popular.
South Asia, primarily India, also attracts large numbers of UK
patients, making it the most frequently visited non-European
country, with a relatively stable pattern of travel to India, Pakistan,
and in much lower numbers Sri Lanka and Bangladesh, possibly
reflecting a diaspora effect. In contrast, East Asia shows a different
pattern, with virtually no medical travellers recorded by the IPS
prior to 2003, yet by 2010 15% of all UK medical travellers went
to East Asia. This increase of 430% is unlikely to be solely related
to diaspora patients, but does correlate with many South East
Asian countries marketing strategies at this time [11].
Based on the IPS data, and patient interviews, treatment specific
destinations emerge. For example, UK dental patients increasingly
travel to Hungary and Poland, which corresponds to the varied
availability of NHS dental treatment over the last decade [12].
Fertility tourists often travel to countries in Eastern Europe,
Cyprus and Spain possibly owing to more easily accessible
gametes, and less stringent regulation which allows anonymous
donation as well as a greater number of embryos transferred [13].
Inward Medical Travel
As evident in Figure 1, data from the IPS suggests that
international patient inflows to the UK (independent sector and
NHS private services) were in the region of 52,000 in 2010. Data
over the decade also confirms that while growing, the overall
numbers of patients travelling into the UK to access medical
services is rising at a much slower rate than UK residents travelling
out for care. So, contrary to some popular media reports, far from
being a net importer of patients, the UK is now a clear net
exporter of medical travellers.
Major source countries for patients coming into the UK include
Spain, Greece, Cyprus and the Middle East. The number of
Greeks and Cypriots travelling into the UK to access treatment
rose rapidly in 2009 and 2010. These figures may reflect a change
as a result of the economic crisis, which in turn has meant severe
public sector cuts in these countries, including in health [14].
Similarly, while medical tourists from Ireland may choose to travel
to access treatment not available there, including termination of
pregnancies, the rapid increase in patients from Ireland in recent
years may reflect the cuts in the health sector there and greater
numbers of UK citizens resident in Ireland returning to the UK
for treatments (see Figure 4). The ‘dip’ in both inbound and
outbound medical travel evident in Figure 1 in 2008 may be
attributable to the onset of the crisis. Examining the number of
travellers by quarter found a much lower number of inward and
outward medical travellers in Quarter 3 of 2008 during the onset
of the crisis, than the rest of the year, or Quarter 3 in 2009. In the
case of Irish, Spanish (and perhaps French) residents, it is highly
likely that a substantial number will be UK expats and it is unclear
whether these engage in out-of-pocket medical treatment (in the
private sector or NHS) or whether they accept NHS services free
at the point of use for which they may (or may not) be eligible.
A further significant number of patients travel from the Middle
East (specifically from the United Arab Emirates and Kuwait)
although visitor numbers from both countries dropped sharply in
2008 and 2009 respectively. Despite some variation between years,
a stable inward flow of medical travellers from Nigeria is also
evident over the past decade, perhaps reflecting the growing
wealth of some sections of that population.
International activity within hospital trusts. Our Free-
dom-of-Information requests suggest that Trusts could not always
clearly identify international patients within their pool of private
patients because nationality was not recorded when they
underwent treatment and nationality/place of residence may
differ. Looking at the 28 Trusts within our sample, their
international activity ranged from relatively marginal to being
one-third of their total private work.
Where Trust managers were interviewed (at seven sites) they
spoke of international patient flows and activities within the
context of pressure on NHS resources, and pre-existing interna-
tional activities and linkages. Commercial imperatives were
balanced with strong statements regarding the core NHS role,
centred on NHS services and prioritising NHS patient care.
UK Medical Tourism
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International patient activity was typically specialist where it was
not possible to treat locally because of relatively small volumes and
the complex nature of treatment required. Relationships, primarily
clinical ones, for example where a clinician from aboard had
trained or worked in a UK hospital were paramount in
maintaining flows of international patients. Established practices
of education, training, consultancy and linkages were reported to
help facilitate referrals. Rather than systematic links these personal
networks appeared paramount in linking UK hospitals to
international patients.
What is the Impact of Medical Tourism on the NHS
‘Bottom-line’?
Using the IPS data, analysis from interviews with medical
tourists, academic literature and published NHS data we
calculated possible costs and savings for the NHS for three types
of medical tourism identified (see annex S1 for calculations).
Fertility tourism. Based on data from the Office of National
Statistics on multiple births in the UK and evidence from a
hospital in London which found over a quarter of multiple births
were in women who had travelled abroad for fertility treatment
[15], we estimated the cost incurred through multiple births as a
result of individuals travelling abroad for fertility treatment.
Figure 1. The number of people who travelled into or out of the UK for medical treatment during the period 2000–2010.
doi:10.1371/journal.pone.0070406.g001
Figure 2. Map depicting total numbers of medical travellers and their destinations from the UK over the period 2000–2010.
doi:10.1371/journal.pone.0070406.g002
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Multiple pregnancies pose risks to mothers and children. We
concentrated on the actual costs of multiple births per se as the
exact needs throughout pregnancy and possible complications are
highly variable between women, and thus our estimates will be
highly conservative. We calculated the additional cost of a twin or
triplet over singleton birth resulting from fertility travel in 2010 to
be £15.5 million.
The long-term costs resulting from assisted reproductive
technologies, including multiple pregnancies will not differ
between medical tourists and fertility patients who received care
in the UK. However, our research indicates that patients will
travel in search of reproductive care to countries with regulations
that will allow fertility treatment likely to result in a higher number
of multiple births. Any effort to address the rise in multiple births
in the UK therefore needs to take account of medical travel and
involve specific targeted information to be effective.
Cosmetic tourism. We also calculated the likely cost of
complications resulting from cosmetic tourism based on a recent
study by Miyagi et al. [16], who described a cohort of patients in a
tertiary facility which reported problems arising from cosmetic
surgery undertaken abroad over a period of three years. The
authors calculated the cost of treatment provided within the NHS
for complications and highlighted the reimbursement received by
the hospital from the PCT (which was less than the expenditure of
the hospital). Based on our calculations complications of medical
tourists are at a cost of £8.2 million per annum within the NHS.
Bariatric surgery. Compared to other types of tourism
discussed, bariatric tourism may represent savings rather than
costs for the NHS, as well as wider social savings. With 25% of the
UK population classified as clinically obese, the financial impact of
obesity on the NHS is calculated as £4.3billion by the DoH [17].
Obesity also has wider costs for social services. For example, a
study by the National Office of Accounting estimated that 18
million working days were lost due to obesity with surgery offering
potential savings. Hawkins et al. [18] demonstrated that there was
a 32% increase in bariatric patients in paid work after surgery.
Based on these estimates, the 13 bariatric tourists interviewed
for this research would represent a saving of £112,506 (in cost of
procedure and in future health care and social services savings).
Even as a high estimate, the key point remains that patients
travelling abroad to receive bariatric surgery are likely to represent
a saving to the NHS and social services. Further research on the
longitudinal effects of bariatric surgery is needed and now
underway in the University of Glasgow at the Surgical Obesity
Treatment Study (ScOTS).
Income Generated by Inbound Medical Travellers
Income generated by inbound medical travellers can be divided
into additional tourism revenue, capturing the general expenditure
related to patients visit to the UK, and medical expenditure
(revenue to hospital).
Tourism revenue from all inbound medical
travelers. Tourism revenue by medical travellers to the UK
per annum is based on the most recent IPS data for inbound
medical travellers (2010). As respondents in the IPS survey
specifically state they are visiting for health care, it is assumed they
would not have otherwise have visited the UK, and thus are an
addition to visitor/tourist numbers to the UK. Hence, any
spending would be seen to be a net benefit not otherwise coming
to the UK.
Based on hospital data for patients treated within NHS
hospitals, it can be assumed that 20% of inbound medical
travellers receive treatment as inpatients, the remainder as day-
case procedures. Expenditure was calculated for patients staying in
the UK for a number of different scenarios, ranging from those
who stay for four days to receive outpatient treatment to patients
who receive in-patient treatment for 10 days and stay a further two
weeks for follow-up (see Table 1). Assumptions were based on
Figure 3. Pie Chart showing total outward medical travel by UK residents by destination region over the time-period 2000–2010.
doi:10.1371/journal.pone.0070406.g003
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interview data collected and on an average hospital stay of
inpatients (not just medical tourists) in 2010 to 2011 from the NHS
Hospital Episode Statistics. These assumptions were that: patients
likely arrive some days before treatment and remain additional
days to fully recuperate or even take the opportunity for additional
tourism activities; people travel with one companion, and
travellers from the Middle East travel with two, and that these
are not captured by the IPS (based on interview data and
corroborated by a 2008 national survey conducted by Which?).
This seems reasonable given the higher foreign patient number
captured from the FOI letters and interview data from patients
who often reported reluctance to be identified as medical tourists
possibly due to the negative public image of medical tourism,
making it unlikely that accompanying persons will identify as
medical tourists. Cost of accommodation was calculated at £80
per night and £100 per day as spending for patients when they
were not in hospital and for their travel companions.
Figure 4. Nine most common countries of origin for those who travelled to the UK for medical (2000–2010).
doi:10.1371/journal.pone.0070406.g004
UK Medical Tourism
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Calculations are summarized in Table 1 and further explained
in Annex S1 suggest that, even without taking the cost of the actual
medical treatment into account, medical tourists to the UK
contribute around £219 million in additional ‘tourism spending’
to the UK economy per year.
Healthcare revenue from all inbound medical
tourists. To estimate the spend on medical procedure by
inbound medical tourists in NHS facilities as accurately as
possible, we submitted Freedom-of-Information requests for data
on income from private patients in NHS hospitals, including UK
and non-UK patients, to 28 NHS Foundation hospitals. Of 28
hospitals 19 were able to provide data on the percentage of income
that resulted from non-UK resident patients and number of non
UK residents treated as private patients. Authors excluded
Moorfields Eye Hospital, as a review of the data across different
hospitals indicated this as an outlier. Given the focus on eye
medicine, it has a very large number of patients visiting for
outpatient procedures at a lower per cost treatments compared to
other elective procedures. The remaining 18 reported a combined
income from private patients of £195 million over a period of 12
months between 2010–2011.
Those who were able to provide differentiated data indicated
that £42 million of their total income was from non-UK resident
patients; looking across these 18 hospitals, this meant close to 25%
of their private income was from incoming medical tourists. While
our sample of hospitals was weighted towards large London-based
facilities which do experience a higher number of international
patients, income ranged vastly between hospitals surveyed: from
over £20million to just £2,466 with a mean of £2.5million.
Those hospitals that were able to report numbers of patients
reported a total of 6,722 patients from abroad out of a total of
88,775 private patients counted, i.e. seven percent of private
patients were inbound medical tourists. It might therefore appear
that medical tourists may be especially profitable, yielding close to
a quarter of revenue from only 7% of volume. For a detailed listing
of patients and income per hospital, see Annex S2.
Discussion
Results confirm that a small but increasing number of UK
patients are travelling abroad to receive medical treatment.
Medical travel is complex and not a uniform phenomenon. The
majority of UK patients travel within Europe, but an increasing
number are seeking treatment further afield. Patients are traveling
specifically to Poland and Hungary, and increasingly to India and
East Asia. Diaspora, country-specific marketing campaigns, and
specific specialism’s seem to determine patterns of flows of UK
patients seeking care abroad. Patients returning from treatment
abroad experience complications.
The analysis demonstrates both the possibility of costs and
savings to the NHS as a result of patients travelling abroad, which
need to be considered. Unsurprisingly, the largest numbers of
inbound medical tourists were in the large hospitals which are
internationally known for their specialism; foremost amongst these
Great Ormond Street Hospital for Sick Children which reported
income of over £20million from 656 patients. Data received and
summarised in Appendix 2 also highlights the variation in the
percentage of income that international revenue represents for
hospitals; to some, especially the large hospitals in London, it
marks a significant proportion of private patient income while for
others it contributes a very small percentage of funding.
Table 1. Calculation of additional spend by incoming medical tourists and their travel companions.
Inbound medical travellers No Nights in hotel Cost hotel Expenditure Total expenditure
52000
Inpatients* 10400
Hospital for ten days 75% (75% from ME) 7800 14 8,736,000 10,920,000 19,656,000
Hospital for five days 25% (5% from ME) 2600 7 1,456,000 1,820,000 3,276,000
Subtotal inpatients 10,192,000 12,740,000 22,932,000
Accompanying persons inpatients
Hospital for ten days 75% (75% from ME) 13650 24 26,208,000 32,760,000 58,968,000
Hospital for five days 25% (5% from ME) 2730 12 2,620,800 3,276,000 5,896,800
Subtotal accompanying persons 28,828,800 36,036,000 64,864,800
Total inpatient and accompanying 39,020,800 48,776,000 87,796,800
Outpatients 41600
4 day stay (25%) 10400 4 3,328,000 4,160,000 7,488,000
7 day stay (40) (2.75% ME) 16640 7 9,318,400 11,648,000 20,966,400
14 day stay (35%) (2%ME) 14560 14 16,307,200 20,384,000 36,691,200
Subtotal outpatients 28,953,600 36,192,000 65,145,600
Accompanying persons outpatients 41600
4 day stay (25%) 10400 4 3,328,000 4,160,000 7,488,000
7 day stay (40) (2.75% ME) 17098 7 9,574,880 11,968,600 21,543,480
14 day stay (35%) (2%ME) 14809 14 16,586,080 20,732,600 37,318,680
Subtotal accompanying persons OP 42307 29,488,960 36,861,200 66,350,160
Total outpatient and accompanying 131,495,760
Total 219,292,560
doi:10.1371/journal.pone.0070406.t001
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Our analysis of data suggests that the UK is now a net exporter
of medical tourists. While incoming medical tourists may be less
likely to declare treatment as primary purpose for their visit to the
UK than outbound tourists, data over time clearly shows a greater
acceleration in outbound over inbound medical tourists. Despite
the variations in numbers of patients visiting different hospitals and
in the income per patient, the number of medical tourists was
comparatively smaller than the percentage of income generated by
them (7% of patients generating close to 25% of private income).
These figures suggest that non-UK residents travelling to the UK
for medical treatment seek high-end specialist expensive proce-
dures, and may generate substantial revenue. Additional numbers
of patients for specialist procedures may also help NHS doctors
with surgical learning curves.
The changing destinations of UK travellers and the differing
origins of those travelling to the UK show that medical travel is a
dynamic phenomenon, which can rapidly increase and change.
This highlights the importance of continuous routine monitoring
to understand medical tourism and to enable researchers,
professionals and policymakers to better consider the costs and
benefits of medical tourism to the UK.
UK residents who had travelled abroad reported experiencing
complications following their return, which echoed case reports in
the literature. While we calculated potential costs of these to the
NHS, complications experienced also pose an ethical question.
There is currently no guidance or regulation on risk or safety for
UK residents who consider travelling abroad for treatment.
Potential savings as a result of medical travel, especially evident
from bariatric patients here, are noteworthy especially at a time of
constrained public resources.
Our findings from NHS Trusts indicates that for those wishing
to increase their private income as a result of the income cap being
raised foreign private patients may be more attractive than
domestic private patients.
While this particular research focused on the impact of medical
tourism on the UK NHS, the findings give an indication of
possible impact of medical tourism in other countries. They are
likely to have particular resonance for other universal public health
systems.
Strengths and Weaknesses of the Study
While the study used the most robust data set available to
measure volume of medical tourism to the UK, the International
Passenger Survey, it has several weaknesses. The IPS only surveys
0.2% of travellers entering and leaving the UK. In addition,
inbound figures on medical tourists do not provide information on
whether these are accessing treatment in the public or the private
sector. Interviews with medical tourists also suggested that not all
may identify themselves as travelling for medical purposes.
Moreover, costs calculated are based on published literature often
drawing on small samples.
Thus, although data and analysis presented here represent the
most comprehensive analysis of inbound and outbound medical
tourism to date, they clearly identify the significant gap in
understanding of this increasingly important phenomenon. The
particular strength of the findings here lies in the mixed–methods
approach. Authors undertook the first comprehensive analysis of
the IPS from a medical tourism perspective. Findings were
triangulated by drawing on published literature, and by analysis of
interviews with 77 UK medical tourists. Similarly, the cost
estimates were developed based on results from interviews, costs
reported in the published literature, the IPS data set and freedom
of information requests to 28 hospital foundation trusts. Hence,
each finding has carefully been considered and based on more
than one data source.
Directions for Future Research
The impact of medical tourism warrants better monitoring.
Findings demonstrate impact in terms of possible costs and
benefits and the highly dynamic nature of the phenomenon means
that the absolute numbers presented here could grow rapidly.
Only continuous monitoring will allow better understanding and
informed policy-making to ensure patient safety.
Estimates of cost presented here mark a first step based on the
limited data available. To better understand costs and potential
savings of medical tourism requires not only better data on volume
of travel but also on the differences in long-term health outcomes
between patients who travelled and those having received
treatment at home. Further research of comparative outcomes is
needed.
This research does not explore the ethical dimensions that are
involved in many of the considerations relating to medical tourism,
including why patients opt to receive care outside of the UK.
While data here represents the economic costs of complications
experienced by patients these obviously will have to be considered
alongside considerations of patient safety.
Conclusions
UK medical tourism is a growing phenomenon. To fully
understand its implications and guide policy on issues such as NHS
global activities and patient safety will require investment in
further research and monitoring. Despite existing data limitations
it is evident that UK medical tourism is dynamic and changing.
Findings indicate costs arise where patients travel abroad and
return with complications. Analysis also indicates possible savings
in the case of specific procedures especially in future health care
and social costs averted. Inbound medical tourists offer potentially
high income to NHS hospitals. Results of this research may also be
indicative of the impact of medical tourism in other public health
systems.
Disclaimer
The views and opinions expressed therein are those of the
authors and do not necessarily reflect those of the HS&DR
Programme, NIHR, NHS or the Department of Health.
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